Ken Ebihara Selected Research

Ken Ebihara Research Topics

Disease

18	Insulin Resistance 05/2024 - 01/2002
17	Obesity 10/2022 - 01/2002
6	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 10/2022 - 05/2004
6	Body Weight (Weight, Body) 01/2020 - 12/2009
5	Lipoatrophic Diabetes Mellitus 05/2024 - 08/2004
4	Neoplasms (Cancer) 06/2023 - 02/2007
4	Fatty Liver 10/2022 - 11/2012
4	Insulinoma 05/2021 - 12/2005
4	Hypoglycemia (Reactive Hypoglycemia) 05/2021 - 09/2002
4	Hyperglycemia 09/2020 - 01/2005
4	Atherosclerosis 01/2020 - 01/2014
4	Lipodystrophy 06/2019 - 10/2012
3	Familial Partial Lipodystrophy (Dunnigan Syndrome) 01/2023 - 12/2009
3	Inflammation (Inflammations) 01/2020 - 05/2010
3	Autism Spectrum Disorder 05/2019 - 01/2017
2	Diabetes Mellitus 05/2024 - 01/2024
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 04/2021
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2017
2	Weight Loss (Weight Reduction) 09/2020 - 04/2010
2	Type 2 Diabetes Mellitus (MODY) 12/2016 - 10/2014
2	Glucagonoma 01/2013 - 12/2005
2	Diabetes Complications 09/2011 - 02/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011 - 02/2009
2	Hypertrophy 04/2010 - 01/2005
2	Hyperphagia (Overeating) 07/2009 - 02/2009
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2009 - 01/2005
2	Hypertension (High Blood Pressure) 02/2007 - 01/2002
1	Ketosis 05/2024
1	Achlorhydria (Hypochlorhydria) 06/2023
1	Hypokalemia 06/2023
1	Vipoma (WDHA) 06/2023
1	Diarrhea 06/2023
1	Thyroiditis 05/2023
1	Graves Disease (Basedow Disease) 05/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	COVID-19 01/2023
1	Severe Acute Respiratory Syndrome 01/2023
1	Leukemia 01/2023
1	Non-alcoholic Fatty Liver Disease 10/2022
1	Adenoma (Adenomas) 08/2022
1	Hyperaldosteronism (Conn Syndrome) 08/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 04/2021
1	Kallmann Syndrome (Kallmann's Syndrome) 04/2021

Drug/Important Bio-Agent (IBA)

20	LeptinIBA 10/2022 - 01/2002
16	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2002
14	Insulin (Novolin)FDA Link 01/2024 - 01/2002
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2007
4	LipidsIBA 01/2020 - 08/2005
4	Hormones (Hormone)IBA 04/2012 - 01/2005
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023 - 10/2016
3	Messenger RNA (mRNA)IBA 01/2023 - 12/2005
3	CholesterolIBA 01/2020 - 11/2018
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 12/2005
3	AMP-Activated Protein KinasesIBA 11/2012 - 02/2009
3	MelanocortinsIBA 07/2009 - 01/2002
2	empagliflozinIBA 05/2024 - 01/2024
2	SodiumIBA 01/2024 - 09/2020
2	C-PeptideIBA 01/2023 - 02/2007
2	Pioglitazone (Actos)FDA Link 01/2023 - 12/2009
2	LipopolysaccharidesIBA 01/2023 - 11/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 11/2015
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2013
2	Therapeutic UsesIBA 10/2022 - 11/2012
2	ThiazolidinedionesIBA 10/2022 - 12/2009
2	CollagenIBA 01/2022 - 11/2015
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2021
2	Nonsense Codon (Nonsense Mutation)IBA 04/2021 - 05/2004
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2020 - 04/2012
2	Insulin ReceptorIBA 09/2020 - 06/2019
2	ipragliflozinIBA 09/2020 - 12/2016
2	EnzymesIBA 01/2020 - 04/2010
2	kamisyoyo sanIBA 05/2019 - 01/2019
2	Pregnanolone (Allopregnanolone)IBA 01/2019 - 01/2017
2	CytokinesIBA 11/2018 - 11/2015
2	Streptozocin (Streptozotocin)FDA Link 10/2014 - 02/2009
2	Islet Amyloid PolypeptideIBA 04/2012 - 01/2011
2	AngiotensinogenIBA 09/2010 - 04/2010
2	GlucocorticoidsIBA 05/2010 - 05/2009
2	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 02/2009 - 01/2002
1	KetonesIBA 05/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2024
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 06/2023
1	AntibodiesIBA 05/2023
1	27-hydroxycholesterolIBA 01/2023
1	OxysterolsIBA 01/2023
1	7-ketocholesterolIBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	cholesterol 25-hydroxylaseIBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	25-hydroxycholesterolIBA 01/2023
1	Rosiglitazone (Avandia)FDA Link 10/2022
1	AldosteroneIBA 08/2022
1	Sterol Regulatory Element Binding Protein 1IBA 01/2022
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2022
1	lanreotide (Somatuline)FDA Link 05/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2021

Therapy/Procedure

8	Therapeutics 01/2019 - 08/2004
2	Gastrectomy 11/2015 - 01/2014